Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans
Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans
Researchers involved in a long-term project to identify viruses of concern have now assessed the risk factors that could help forecast which pathogens are the most likely to spillover from wildlife to people.
Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans
Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans

Researchers involved in a long-term project to identify viruses of concern have now assessed the risk factors that could help forecast which pathogens are the most likely to spillover from wildlife to people.

Researchers involved in a long-term project to identify viruses of concern have now assessed the risk factors that could help forecast which pathogens are the most likely to spillover from wildlife to people.

SARS-CoV-2
J&J COVID-19 Vaccinations Resume After Temporary Shutdowns
J&J COVID-19 Vaccinations Resume After Temporary Shutdowns
Shawna Williams | Apr 9, 2021
Vaccinations with the Johnson & Johnson jab paused at several sites earlier this week after an unusual number of people experienced adverse reactions, but the CDC says there’s no cause for concern.
How Infectious Diseases Affect the Brain
How Infectious Diseases Affect the Brain
The Scientist Creative Services Team | Apr 8, 2021
From a loss of taste to dementia, infectious agents cause an array of neurological symptoms.
Most Kids with MIS-C Report Few or No COVID-19 Symptoms: Study
Most Kids with MIS-C Report Few or No COVID-19 Symptoms: Study
Kerry Grens | Apr 7, 2021
A review of hundreds of cases finds that only a minority of patients noted being sick with a coronavirus infection prior to developing the severe inflammatory condition.
Scientists Reverse Engineer mRNA Sequence of Moderna Vaccine
Scientists Reverse Engineer mRNA Sequence of Moderna Vaccine
Lisa Winter | Apr 6, 2021
Stanford University researchers determined the code from spare drops in discarded vials of the COVID-19 vaccine and published it on GitHub.
LabTalk Podcast - Predicting the Immune Response with Single-Cell Analysis: Autoimmunity, Vaccination, and COVID-19
LabTalk Podcast - Predicting the Immune Response with Single-Cell Analysis: Autoimmunity, Vaccination, and COVID-19
The Scientist Staff | Mar 31, 2021
Researchers identify signatures that predict how a person will respond to an immune system stimulus.
Securing the Antibody Supply Chain through Recombinant Antibody Technology: A COVID-19 Case Study
Securing the Antibody Supply Chain through Recombinant Antibody Technology: A COVID-19 Case Study
The Scientist Creative Services Team in collaboration with Sartorius Corporation | Mar 29, 2021
Nicholas Hutchings will discuss how recombinant antibody technology can speed up the response to a pandemic.
Pfizer Vaccine Induces Immune Structures Key to Lasting Immunity
Pfizer Vaccine Induces Immune Structures Key to Lasting Immunity
Katarina Zimmer | Mar 25, 2021
In the armpit lymph nodes of people who had received the mRNA vaccine against SARS-CoV-2, researchers found germinal centers needed to generate long-lived antibody-making cells.
Q&A: Data Gaps Hinder Monitoring of SARS-COV-2 Variants
Q&A: Data Gaps Hinder Monitoring of SARS-COV-2 Variants
Jef Akst | Mar 24, 2021
Martha Nelson of the National Institute of Allergy and Infectious Diseases talks about the need to balance data sharing and patient privacy concerns when tracking the spread of variants.
AstraZeneca’s COVID-19 Shot Completely Prevented Severe Disease
AstraZeneca’s COVID-19 Shot Completely Prevented Severe Disease
Kerry Grens | Mar 22, 2021
The vaccine was 79 percent effective at blocking symptomatic infections, according to data from a Phase 3 trial in the US, Chile, and Peru. A US safety oversight board says the data might be incomplete.